GLP-1 & Obesity
GLP-1 medicines treat obesity and diabetes, and have grown into one of the largest drug categories ever launched. Their reach extends past medicine, because a change in how much people eat moves whole consumer industries.
92 stocks
Increased
Reduced
Net increased
Funds Holding
3,825
Funds Holding Change
+20
Funds Holding Growth
+0.5%
Value
$770B
Holding in Top 10
355
Top 10 Change
+38
Top 10 Growth
+12%
Value Growth
+2%
New
187
Increased
1,772
Reduced
1,567
Closed
115
Capital Inflow
$26.5B
Capital Outflow
$21.6B
Net Capital Flow
+$4.84B
Capital Flow Change
+$33M
Calls
$9.76B
Puts
$9.76B
Net Calls
+$462K
Put/Call Ratio
1